01/13/2026
“With uveal melanoma, there is a high rate of metastasis even after successfully treating the primary tumor. We want to better understand and identify the early genetic events that occur so that we can more precisely treat select small tumors at an earlier stage and hopefully, improve patient outcomes, including survival.” – Timothy Fuller, MD
Texas Retina's Dr. Timothy Fuller, in collaboration with and under the leadership of Dr. J. William Harbour, the Chair of the Department of Ophthalmology at UT Southwestern Medical Center, participated in a multi-center clinical research study through the Collaborative Ocular Oncology Group (COOG) to better understand the early genetic evolution and malignant transformation of uveal melanoma, a rare and aggressive eye cancer. The results were recently published in the journal Nature Communications.
Learn more and access the full article: https://www.texasretina.com/2026/01/13/new-research-on-early-genetic-evolution-of-driver-mutations-in-uveal-melanoma